Cooper Companies Inc (NYSE:COO) Shares Sold by MetLife Investment Advisors LLC
MetLife Investment Advisors LLC decreased its stake in Cooper Companies Inc (NYSE:COO) by 2.2% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,431 shares of the medical device company’s stock after selling 322 shares during the quarter. MetLife Investment Advisors LLC’s holdings in Cooper Companies were worth $3,398,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the company. Tower Research Capital LLC TRC raised its holdings in Cooper Companies by 783.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,033 shares of the medical device company’s stock worth $479,000 after purchasing an additional 1,803 shares during the period. Marshall Wace LLP acquired a new position in Cooper Companies in the 2nd quarter worth about $591,000. Aristotle Atlantic Partners LLC acquired a new position in Cooper Companies in the 2nd quarter worth about $3,767,000. Macquarie Group Ltd. raised its holdings in Cooper Companies by 21.0% in the 2nd quarter. Macquarie Group Ltd. now owns 15,410 shares of the medical device company’s stock worth $3,629,000 after purchasing an additional 2,675 shares during the period. Finally, Bank of America Corp DE raised its holdings in Cooper Companies by 29.1% in the 2nd quarter. Bank of America Corp DE now owns 174,948 shares of the medical device company’s stock worth $41,193,000 after purchasing an additional 39,456 shares during the period. Hedge funds and other institutional investors own 97.07% of the company’s stock.
Shares of Cooper Companies stock traded up $5.63 during mid-day trading on Friday, reaching $256.22. 302,292 shares of the stock traded hands, compared to its average volume of 413,819. Cooper Companies Inc has a fifty-two week low of $216.47 and a fifty-two week high of $280.10. The stock has a market capitalization of $13.62 billion, a P/E ratio of 26.41, a PEG ratio of 2.22 and a beta of 0.67. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.58 and a quick ratio of 1.54.
A number of equities analysts recently weighed in on the company. Zacks Investment Research raised Cooper Companies from a “sell” rating to a “hold” rating in a report on Monday, October 1st. ValuEngine raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Thursday, September 27th. Raymond James upped their price target on Cooper Companies from $270.00 to $300.00 and gave the stock an “outperform” rating in a report on Friday, September 21st. BMO Capital Markets increased their target price on Cooper Companies from $280.00 to $285.00 and gave the company an “outperform” rating in a report on Friday, August 31st. Finally, Oppenheimer set a $270.00 target price on Cooper Companies and gave the company a “hold” rating in a report on Friday, August 31st. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $274.11.
In other news, VP Randal Golden sold 1,731 shares of the company’s stock in a transaction that occurred on Thursday, September 27th. The stock was sold at an average price of $275.86, for a total value of $477,513.66. Following the completion of the sale, the vice president now directly owns 1,154 shares in the company, valued at $318,342.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert S. Weiss sold 58,543 shares of the company’s stock in a transaction that occurred on Wednesday, September 5th. The shares were sold at an average price of $252.82, for a total value of $14,800,841.26. Following the completion of the sale, the director now owns 157,710 shares of the company’s stock, valued at $39,872,242.20. The disclosure for this sale can be found here. Insiders sold 80,809 shares of company stock valued at $20,740,667 over the last 90 days. Company insiders own 1.60% of the company’s stock.
Cooper Companies Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Further Reading: What kind of dividend yield to CEF’s pay?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.